Curigliano G, Shapiro GI, Kristeleit RS, Abdul Razak AR, et al. A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with
other anti-tumour agents for patients with advanced solid tumours and
triple-negative breast cancer. Br J Cancer 2022 Nov 5. pii: 10.1038/s41416-022-02025.
PMID: 36335217